What is Evommune 's EBIT?

Evommune (EVMN) reported EBIT of -$682.81K in Q1 2026.

How has Evommune 's EBIT changed year-over-year?

Evommune 's EBIT decreased by 2027.1% year-over-year, from -$32.1K to -$682.81K.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

Evommune EVMN EBIT

EBIT at other companies

Bausch + LombBLCO

$33M+140%

BillionToOne, Inc. BLLN

$17.83M+870%

Perrigo CompanyPRGO

-$372.3M-894%

PfizerPFE

——

Hims & Hers HealthHIMS

——

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Calculated from Evommune ’s reported figures.

−$682.8Koperating income+$25.8Kinterest expense=-$682.81K

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's EBIT?: Evommune (EVMN) reported EBIT of -$682.81K in Q1 2026.
How has Evommune 's EBIT changed year-over-year?: Evommune 's EBIT decreased by 2027.1% year-over-year, from -$32.1K to -$682.81K.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.